Alain Algazi, MD

2 locations · Regents of the University of California · UCSF Medical Group Business Services

Hospitals listed: UCSF Medical Center. That is not proof they admit you there this week.

12 plans · 2 carriers

Licence A93703 · Current

Licensed to practise in California · since 2006 · expires 2028-01-31 · University of California, Los Angeles School of Medicine.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.

Specialty certification

• American Board of Internal Medicine - Medical Oncology

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

• UCSF Medical CenterSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of University of California Health, which runs 12 hospitalsHome of UCSF Helen Diller Family Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 81% would definitely recommend it
  Overall rating: 4 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 4.9 (3.79 to 6.02) · 7,590 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 12.8 (11.3 to 14.4) · 2,019 cases, Jan 2024 – Dec 2024Better than the national rate — Death rate among surgical inpatients with serious treatable complications: 139.4 (110.22 to 168.58) · 452 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.622, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.626, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.491, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.7 to 1) · 2,336 cases, Jan 2024 – Dec 2024

$121,535

Medicare paid this office $121,535 for 214 people. Most of that is long return visits and Botox.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Who their Medicare patients are

214 Original Medicare patients in 2024. Average age 74 · Under 65 7% · 85 and older 8% · Women 34% · Also on Medicaid 24% · Health risk score 2.42. Above the middle of the specialty; the typical hematology-oncology clinician is at 2.04.

Conditions among them: High blood pressure 72% · Diabetes 24% · Coronary heart disease 23% · Chronic kidney disease 23% · Cancer 21% · Depression 21% · Atrial fibrillation 18% · Heart failure 16% · COPD 14% · Stroke 13% · Dementia 7%.

The office billed $787,341, Medicare allowed $157,773 and paid $121,535; for 1,677 services of 17 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

$36,484 in 2024

Medicaid paid $36,484 for 279 billed services this clinician did in 2024, up to 28 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

$876,041

Pharmacies billed $876,041 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 7% of their Part D prescriptions (22 of 305) in 2024. Above the middle of the specialty; the typical hematology-oncology clinician is at 5%.

232 generic and fewer than 11 brand-name prescriptions · $876,041 in drug cost · 18 antibiotic prescriptions to 14 people.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Year by year

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

$10,029 in 2024

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Research money

Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.

Medicare did not publish checkup rates for this clinician.

NPI

1821289794

Licence

CA A93703California A93703: Current · expires 2028-01-31

Trained

University of California, Geffen School of Medicine, 2004 · 22 years ago

Group

Regents of the University of California · UCSF Medical Group Business Services

Video visits

Lists video visits

Gender

Male